Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Normothermic vs Hyperthermic Oxaliplatin HIPEC in Peritoneal Metastases
NCT01575730Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- May 2012
- Primary completion
- Mar 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in peritoneal carcinomatosis (PC), sponsored by Ghent University Hospital. Started May 2012; status: completed.
02
Drugs
oxaliplatin
03
Conditions
peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT01575730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01575730.